A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Nuveen Short Term Reit ETF stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 38,795 shares of NURE stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,795
Previous 35,830 8.28%
Holding current value
$1.2 Million
Previous $1.11 Million 7.32%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$28.8 - $31.24 $85,392 - $92,626
2,965 Added 8.28%
38,795 $1.19 Million
Q4 2023

Feb 09, 2024

BUY
$25.03 - $31.22 $190,628 - $237,771
7,616 Added 26.99%
35,830 $1.11 Million
Q3 2023

Oct 24, 2023

BUY
$26.93 - $31.38 $347,019 - $404,362
12,886 Added 84.07%
28,214 $766,000
Q2 2023

Jul 13, 2023

BUY
$28.95 - $30.83 $443,745 - $472,562
15,328 New
15,328 $466,000
Q2 2022

Jul 13, 2022

SELL
N/A
-20,336 Closed
0 $0
Q1 2022

May 12, 2022

SELL
N/A
-222 Reduced 1.08%
20,336 $0
Q4 2021

Feb 03, 2022

BUY
N/A
20,558 New
20,558 $0

Others Institutions Holding NURE

About NUVEEN SHORT-TERM REIT ETF


  • Ticker NURE
  • Sector ETFs
  • Industry ETFs
More about NURE
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.